A detailed history of North Star Asset Management Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, North Star Asset Management Inc holds 53,149 shares of TXG stock, worth $1.25 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
53,149
Previous 43,635 21.8%
Holding current value
$1.25 Million
Previous $1.64 Million 36.9%
% of portfolio
0.05%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$19.45 - $37.37 $185,047 - $355,538
9,514 Added 21.8%
53,149 $1.03 Million
Q1 2024

May 08, 2024

BUY
$36.08 - $54.3 $107,734 - $162,139
2,986 Added 7.35%
43,635 $1.64 Million
Q4 2023

Feb 01, 2024

SELL
$34.32 - $57.55 $38,987 - $65,376
-1,136 Reduced 2.72%
40,649 $2.27 Million
Q3 2023

Oct 26, 2023

BUY
$40.86 - $62.98 $37,591 - $57,941
920 Added 2.25%
41,785 $1.72 Million
Q2 2023

Aug 09, 2023

SELL
$50.96 - $58.72 $10,701 - $12,331
-210 Reduced 0.51%
40,865 $2.28 Million
Q1 2023

May 10, 2023

BUY
$35.33 - $55.79 $181,101 - $285,979
5,126 Added 14.26%
41,075 $2.29 Million
Q4 2022

Mar 06, 2023

BUY
$24.4 - $41.3 $40,040 - $67,773
1,641 Added 4.78%
35,949 $1.31 Million
Q3 2022

Nov 08, 2022

SELL
$28.48 - $52.59 $161,310 - $297,869
-5,664 Reduced 14.17%
34,308 $977,000
Q2 2022

Jul 28, 2022

SELL
$36.95 - $82.41 $12,230 - $27,277
-331 Reduced 0.82%
39,972 $1.81 Million
Q1 2022

Apr 29, 2022

BUY
$55.7 - $145.79 $314,816 - $824,005
5,652 Added 16.31%
40,303 $3.07 Million
Q4 2021

Feb 07, 2022

BUY
$135.05 - $182.59 $256,865 - $347,286
1,902 Added 5.81%
34,651 $5.16 Million
Q3 2021

Oct 20, 2021

BUY
$145.58 - $192.14 $1.47 Million - $1.94 Million
10,111 Added 44.66%
32,749 $4.77 Million
Q2 2021

Jul 30, 2021

BUY
$134.22 - $202.37 $416,618 - $628,156
3,104 Added 15.89%
22,638 $4.43 Million
Q1 2021

Apr 29, 2021

BUY
$140.25 - $196.86 $2.74 Million - $3.85 Million
19,534 New
19,534 $3.54 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $2.23B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track North Star Asset Management Inc Portfolio

Follow North Star Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on North Star Asset Management Inc with notifications on news.